Our Research

At the Jacobs School, we advance research and discovery to improve health for all. Our multidisciplinary research advances basic and clinical science; we translate those discoveries into clinical care that improves health in our communities. With our eyes on the future, we are increasing the number of students and trainees who pursue careers in research, biomedical science and academic medicine.

Our Research Accomplishments

4/6/20

Postponing spring holiday family gatherings this year due to the COVID-19 global health pandemic may be the best option, suggests Thomas A. Russo, MD, professor of medicine and chief of infectious diseases.

4/2/20

Manoj J. Mammen, MD, has co-authored international guidelines — jointly published in Critical Care Medicine and Intensive Care Medicine — for the management of critically ill adults with coronavirus disease (COVID-19).

4/2/20

Due to the COVID-19 global health pandemic, the Jacobs School of Medicine and Biomedical Sciences has transitioned to a distance learning model for student instruction to reduce density in the campus environment.

4/1/20

The Hepatology Clinic at the Erie County Medical Center (ECMC) continues to gain national and international recognition for its unique approach and exceptional cure rate for hepatitis C.

3/23/20

Medical students at the Jacobs School of Medicine and Biomedical Sciences are donning chef’s coats and toques instead of white coats for a new interprofessional course.

3/23/20

Three Jacobs School of Medicine and Biomedical Sciences faculty members wrote a chapter in the book “Neurological Disorders and Imaging Physics, Volume 3: Application to Autism Spectrum Disorders and Alzheimer’s.”

3/10/20

University at Buffalo researchers have discovered a link between fats in the blood and problems with the arteries in multiple sclerosis (MS) patients.

3/2/20

Kathleen E. Bethin, MD, PhD, and Lucy D. Mastrandrea, MD, PhD, were local investigators in a successful worldwide clinical trial that confirmed that a fast-acting insulin is safe for children with diabetes mellitus.

2/28/20

A basic research breakthrough by Margarita L. Dubocovich, PhD, reporting the effects of new molecules on circadian rhythms in mice could result in treatments for people affected by jet lag, sleep disorders or even depression.

Recent Publications

Recent Research Funding

  • Expanding the toolkit for design of robust phage therapeutic cocktails. Anne Kathryn Kauffman (Principal Investigator), Frank Scannapieco (Co-Investigator). NIH. $438,625. 12/1/2020-11/1/2022.
  • Environmental Health Scholar. Sarah Ventre (Principal Investigator). New York State Children’s Environmental Health Center. 11/1/2020-11/1/2022.
  • Suramin for Radiation-Induced Oral Mucositis. Keith Kirkwood (Co-Principal Investigator). national Institutes of Health. $207,526. 9/1/2020-8/1/2022.
  • MTM 2: Collaborative Research: How does phage life history strategy govern predation in microbiomes?. Anne Kathryn Kauffman (Co-Investigator). NSF. $848,751. 9/1/2020-8/1/2025.